Log in
Enquire now
Glycomine

Glycomine

Glycomine is an early-stage biotech working on replacement therapies for rare diseases.

OverviewStructured DataIssuesContributors

Contents

glycomine.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Pharmaceutical industry
Pharmaceutical industry
Biotechnology
Biotechnology
Health technology
Health technology
Location
San Francisco, California, United
San Francisco, California, United
B2X
B2B
B2B
CEO
‌
Steven Axon
Founder
‌
Steven Axon
Number of Employees (Ranges)
1 – 10
Email Address
info@glycomine.com
Phone Number
+14156175755
Investors
Novo Holdings
Novo Holdings
CTI Life Sciences Fund
CTI Life Sciences Fund
Asahi Kasei Pharma Venture Capital
Asahi Kasei Pharma Venture Capital
‌
Remiges Ventures
‌
Remiges Ventures
‌
Abrdn
Abingworth
Abingworth
Sanderling Ventures
Sanderling Ventures
...
Total Funding Amount (USD)
115,000,000
Latest Funding Round Date
April 16, 2025
CTO
‌
Geoffrey Hird
Latest Funding Type
Series C
Series C

Other attributes

Latest Funding Round Amount (USD)
115,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Glycomine

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.